Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
Kun Wen(Zhujiang Hospital), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Shuofeng Yuan(University of Hong Kong - Shenzhen Hospital), Lin‐Lei Chen(Queen Mary Hospital), Hoi‐Wah Tsoi(University of Hong Kong), Kaiming Tang(University of Hong Kong), Huiping Shuai(University of Hong Kong), Jasper Fuk‐Woo Chan(Hong Kong Science and Technology Parks Corporation), Jianwen Situ(University of Hong Kong), Jian‐Piao Cai(University of Hong Kong), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Xiaojuan Zhang(Jiangnan University), Cuiting Luo(University of Hong Kong), Hongwei Zhou(Institute of Food Science and Technology), Ruiqi Zhang(University of Hong Kong), Kun Wang(Tongji University), Xiaodi Fan(Jinan University)
Cited by 6
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k